Stocksigma LogoStocksigma Logo

Natco Pharma Approves ₹1,279.36 Crore Rights Issue

Natco Pharma's board approved a rights issue of up to 1,70,58,082 equity shares (face value ₹2) at ₹750 per share (₹748 premium), raising up to ₹12,79.36

Natco Pharma Approves ₹1,279.36 Crore Rights Issue

Natco Pharma Ltd · Outcome · 25 Sept 2026, 4:48 pm

Natco Pharma Approves ₹1,279.36 Crore Rights Issue Natco Pharma's board approved a rights issue of up to 1,70,58,082 equity shares (face value ₹2) at ₹750 per share (₹748 premium), raising up to ₹12,79.36 crore. The entitlement ratio is set at 2:21 (2 rights shares for every 21 shares held) with a record date of 1st Oct'26. The issue opens on 12th Oct'26 and closes on 22nd Oct'26, with on-market renunciation from 12th Oct'26 to 16th Oct'26. Outstanding equity will expand from 17,91,09,870 to 19,61,67,952 shares post-issue upon full subscription.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements